Parametric Portfolio Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$3.11M Sell
42,776
-8,746
-17% -$635K ﹤0.01% 2162
2021
Q4
$4.33M Sell
51,522
-1,402
-3% -$118K ﹤0.01% 1969
2021
Q3
$4.77M Buy
52,924
+6,966
+15% +$628K ﹤0.01% 1861
2021
Q2
$4.38M Sell
45,958
-37,904
-45% -$3.61M ﹤0.01% 1934
2021
Q1
$9.55M Sell
83,862
-15,651
-16% -$1.78M 0.01% 1714
2020
Q4
$13.8M Buy
99,513
+11,040
+12% +$1.53M 0.01% 1325
2020
Q3
$7.27M Buy
88,473
+45,539
+106% +$3.74M 0.01% 1609
2020
Q2
$3.36M Buy
42,934
+9,783
+30% +$765K ﹤0.01% 2154
2020
Q1
$1.47M Buy
33,151
+4,818
+17% +$214K ﹤0.01% 2565
2019
Q4
$1.21M Buy
28,333
+5,208
+23% +$222K ﹤0.01% 2963
2019
Q3
$989K Buy
23,125
+3,119
+16% +$133K ﹤0.01% 3034
2019
Q2
$1.27M Buy
20,006
+705
+4% +$44.8K ﹤0.01% 2928
2019
Q1
$1.34M Buy
19,301
+3,557
+23% +$247K ﹤0.01% 2878
2018
Q4
$685K Sell
15,744
-4,518
-22% -$197K ﹤0.01% 3166
2018
Q3
$1.55M Buy
20,262
+1,208
+6% +$92.2K ﹤0.01% 2875
2018
Q2
$1.47M Buy
19,054
+1,196
+7% +$92K ﹤0.01% 2860
2018
Q1
$911K Sell
17,858
-4,217
-19% -$215K ﹤0.01% 3071
2017
Q4
$1.02M Buy
22,075
+8,626
+64% +$400K ﹤0.01% 3010
2017
Q3
$716K Sell
13,449
-439
-3% -$23.4K ﹤0.01% 3224
2017
Q2
$863K Sell
13,888
-18,863
-58% -$1.17M ﹤0.01% 3058
2017
Q1
$2.22M Buy
32,751
+8,353
+34% +$566K ﹤0.01% 2377
2016
Q4
$1.72M Sell
24,398
-3,804
-13% -$267K ﹤0.01% 2478
2016
Q3
$2M Buy
28,202
+5,421
+24% +$385K ﹤0.01% 2337
2016
Q2
$1.11M Sell
22,781
-7,587
-25% -$371K ﹤0.01% 2736
2016
Q1
$1.92M Buy
30,368
+21,191
+231% +$1.34M ﹤0.01% 2429
2015
Q4
$1.03M Sell
9,177
-196
-2% -$22K ﹤0.01% 2745
2015
Q3
$903K Buy
9,373
+1,210
+15% +$117K ﹤0.01% 2395
2015
Q2
$836K Buy
8,163
+1,040
+15% +$107K ﹤0.01% 2926
2015
Q1
$442K Buy
+7,123
New +$442K ﹤0.01% 3345